Moderna COVID-19 Vaccine (2023-2024 Formulation) is a vaccine for the prevention of COVID-19 in individuals 6 months through 11 years of age.
The Moderna COVID-19 Vaccine (2023-2024 Formulation) is an mRNA vaccine encoding the spike protein of the Omicron XBB.1.5 variant. It is authorized for emergency use to prevent COVID-19 in individuals 6 months through 11 years of age. The document explains the vaccine's benefits, risks, administration schedule, contraindications, ingredients, and potential side effects including rare cases of myocarditis and pericarditis. This manual is written in Chinese.
Individuals who had a severe allergic reaction after a previous dose of any Moderna COVID-19 vaccine or to any ingredient of the vaccine should not get it.
No, the vaccine does not contain SARS-CoV-2 virus and cannot cause COVID-19 infection.